Trials / Recruiting
RecruitingNCT06130280
A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer
Ablative Dose Single Fraction MRguided Colorectal Liver Metastasis SBRT
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The researchers are doing this study to see if one session of high-dose contrast-enhanced MRI-guided SBRT (stereotactic body radiation therapy) is effective for colorectal cancer that has spread to the liver. The researchers will evaluate how well the study treatment can prevent the liver metastasis from growing and spreading. In addition, they will see whether it causes any side effects and whether there are any characteristics of the research MRI images that can predict response to treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | MR Guided Single Fraction Stereotactic Body Radiation Therapy (SBRT) | 40Gy single fraction treatment on Elekta Unity using Gd-EOB-DTPA-enhanced MR for image guidance. |
Timeline
- Start date
- 2023-11-08
- Primary completion
- 2026-11-01
- Completion
- 2026-11-01
- First posted
- 2023-11-14
- Last updated
- 2026-02-18
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06130280. Inclusion in this directory is not an endorsement.